The Vigilint Blog

Global Medical News as reported from our Medical Intelligence Center and Leadership Team

Antibiotic Resistance

By Emily Elmore | April 20, 2022

In what is considered the most comprehensive global study of bacterial antimicrobial resistance (AMR), the peer-reviewed Lancet Medical Journal found that nearly 5 million deaths in 2019 were associated with antibiotic-resistant bacterial infections. In addition, the study found that drug-resistance bacteria accounted for 1.2 million deaths in 2019 – more than HIV and malaria. COVID-19… Read more about Antibiotic Resistance

What You Need to Know About the Omicron “Stealth Variant”

By Megan Kasprzak | March 2, 2022

Since the pandemic’s start, the SARS-CoV-2 virus has infected 392 million people and caused 5.7 million deaths worldwide. The highly transmissible omicron variant, first discovered in November 2021, accounts for nearly all active coronavirus infections globally. Recently, headlines have appeared around a new and more powerful subvariant to omicron. The subvariant, also known as the… Read more about What You Need to Know About the Omicron “Stealth Variant”

Free At-Home COVID-19 Tests from the Government

By Megan Kasprzak | January 25, 2022

At-home testing for COVID-19 is an essential tool that can help mitigate the spread of the virus. The US government launched a new website last Tuesday, January 18, allowing households to order up to four free at-home coronavirus tests. Type of At-Home COVID-19 Tests In December, the Biden administration announced the purchase of one billion at-home,… Read more about Free At-Home COVID-19 Tests from the Government

Webinar: SARS-COV-2 Omicron Variant of Concern

By Emily Elmore | December 1, 2021

Join us on December 14th at 11 am EST/8 am PST for a webinar featuring VIGILINT Emergency Medicine Physicians Drs Ossmann and Cellini as they discuss the newly discovered omicron variant and the potential impact on holiday travel. You have questions, and we want to hear from you! Please submit your questions you’d like addressed… Read more about Webinar: SARS-COV-2 Omicron Variant of Concern

COVID-19 Vaccine for Children & The Pandemic’s Impact on Working Parents

By Emily Elmore | November 22, 2021

COVID-19 Vaccine Approved for Children 5-11 Kids 5 and up can now get their age-appropriate dose of the COVID-19 vaccine, which is the most effective way to protect against the virus—hard stop. After a year that saw parents scrambling to find ways to protect their children from illness and keep their kids educated in a… Read more about COVID-19 Vaccine for Children & The Pandemic’s Impact on Working Parents

White House Announces “Path out of the Pandemic”

By VIGILINT Operations Center | September 9, 2021

Today, President Biden announced a six-pronged national strategy to expand the federal government’s response to COVID-19. The Department of Labor is developing a rule that will require all employers with 100 or more employees to ensure their workers are fully vaccinated and require unvaccinated workers to be tested on a weekly basis. In addition, employers… Read more about White House Announces “Path out of the Pandemic”

The Debate: Masks in Schools

By Alex Buckman | September 9, 2021

As summer draws to a close, fall brings unique challenges. The surge of COVID-19 cases, instigated by the Delta variant, has heavily impacted the beginning of the new school year. In July, the CDC recommended that all students and staff wear masks in schools, regardless of vaccination status. The nature of this statement as a… Read more about The Debate: Masks in Schools

Spectators barred from the Olympics due to COVID-19 risk

By Heather Ireland | July 15, 2021

  Nestled amid a global pandemic, athletes from 206 countries are making their way to Japan to compete in the 2020 Tokyo Olympic Games.  Not the first Games to be affected by widespread health concerns: although the novel Zika virus was a concern during the 2016 Rio Olympics, the  World Health Organization (WHO) announced at… Read more about Spectators barred from the Olympics due to COVID-19 risk

Reopening the Schools – Weighing the Risks

By Alex Buckman | March 2, 2021

For nearly a year, schools in the United States have adapted to the pandemic by utilizing distance-learning models with varying success levels. Many studies indicate that the interruption to in-person learning has drastically affected standardized test scores, graduation rates, absenteeism, and social development for all students. The heaviest toll falls on Black, Hispanic, and low-income… Read more about Reopening the Schools – Weighing the Risks

COVID-19 ONE YEAR LATER, Part II: Testing and Vaccines

By Colin Schilly | February 12, 2021

In the second part of VIGILINT’s two-part series COVID-19 1 Year Later, VIGILINT Ops Analyst and blogger Colin Schilly dives into the two critical hallmarks of the pandemic. Testing and vaccines. The development and rollout of several effective vaccines in under a year offer great hope for the pandemic’s end. Sadly, that day may still… Read more about COVID-19 ONE YEAR LATER, Part II: Testing and Vaccines

Monthly Newsletter

Featuring global health news from our Medical Intelligence Center

Sign Up!

Latest Blogs